Stem Cell Treatment for Alopecia Areata (Hair Loss) in Delhi

What causes alopecia areata?

Alopecia areata occurs when the immune system mistakenly targets hair follicles, triggering inflammation and hair loss. Researchers haven’t identified one single trigger, but several contributing factors are well documented:

• Genetics — a family history of alopecia areata or other autoimmune conditions increases individual risk.
• Other autoimmune conditions — alopecia areata is more common in people who also have conditions like thyroid disease, vitiligo, or type 1 diabetes.
• Vitamin D deficiency — associated with alopecia areata in several studies, though not established as a direct cause.
• Environmental triggers — physical or emotional stress, viral infections, and other environmental factors are suspected to play a role in triggering episodes in genetically predisposed individuals, though the exact mechanism isn’t fully understood.

Why this matters for treatment approach

Because alopecia areata is autoimmune in nature, treatment approaches — including stem cell therapy — are being studied partly for their potential to help modulate the immune response, not only to stimulate hair growth directly. If you have a co-existing autoimmune condition, mention this during your evaluation, as it may be relevant to your specific treatment plan.

Related: if your hair loss is more evenly thinning rather than patchy, also review our Anti-Aging page, as broader regenerative skin/hair research sometimes overlaps.

What are the symptoms of alopecia areata?

The hallmark symptom is hair loss in small, round patches, most often on the scalp, though presentation can vary:

• Patchy hair loss — one or more coin-sized bald patches, often appearing suddenly.
• Band-like hair loss (ophiasis pattern) — a band of hair loss along the sides and back of the scalp.
• Widespread hair loss (alopecia totalis/universalis) — complete scalp hair loss or, in rarer cases, loss of all body hair.
• Eyelash or eyebrow loss — can occur alongside or independent of scalp involvement.
• Nail changes — pitting, ridging, or brittleness in some patients, thought to be linked to the same immune process.
• Seasonal pattern — some patients notice episodes beginning or worsening during colder months, though this varies by individual.

What to do if you notice these signs

A sudden patch of hair loss should be evaluated by a dermatologist promptly — see Diagnosis below — both to confirm alopecia areata specifically (rather than a fungal infection, traction alopecia, or another cause) and because earlier evaluation generally allows for a broader range of treatment options.

How is alopecia areata diagnosed?

Diagnosis typically begins with a physical examination of the scalp and a review of family and personal medical history, followed by targeted tests where needed:

Your existing dermatology reports (biopsy results, blood work) can be uploaded for a free specialist review ahead of your consultation.

Stem Cell Treatment for Alopecia Areata

Stem cell therapy for alopecia areata uses adult mesenchymal stem cells, sourced from umbilical cord tissue or adipose (fat) tissue, delivered to the affected follicular areas of the scalp. The aim is to help stimulate dormant follicles and, through mesenchymal stem cells’ known immunomodulatory properties, potentially help regulate the autoimmune activity driving the hair loss — supporting both hair repair and regeneration and hair growth.

Who is a candidate?

You may be considered a candidate if you have:

• A confirmed diagnosis of alopecia areata (patchy, band-pattern, or more extensive) following dermatological evaluation
• Documented inadequate response to, or intolerance of, first-line treatments such as corticosteroid injections or topical immunotherapy
• No active scalp infection or other contraindication identified during evaluation

Extent of hair loss, disease duration, and pattern (patchy vs. totalis/universalis) all affect candidacy and expected response, and your specialist will discuss this directly based on your specific case.

What to expect: the treatment process

1. Consultation and diagnostic review — scalp examination and any existing test results are reviewed by our specialist team.
2. Cell sourcing — preparation of screened donor umbilical cord tissue, or adipose tissue collection (autologous).
3. Lab processing — cells are isolated and quality-tested under controlled laboratory conditions, with a certificate of analysis issued for each batch.
4. Administration — delivered via the method most appropriate to your case; see Implantation below.
5. Follow-up monitoring — periodic scalp assessment over the following months to track regrowth and disease activity.

Stem Cell Implantation for Alopecia Areata

Implantation method depends on your specific diagnosis and the extent of hair loss. Delivery routes used include:

• Intravenous administration
• Intrathecal (lumbar puncture) — used in specific combined-condition cases, not routine for isolated alopecia areata
• Intramuscular
• Intra-arterial
• Subcutaneous
• Targeted scalp injection or micro-needling — the most common route for localized alopecia areata specifically

Your treating specialist selects the appropriate route based on the extent and pattern of your hair loss, not a default protocol. For the general science behind how these routes are chosen, see Stem Cell Delivery Methods.

Improvements Seen After Stem Cell Therapy for Alopecia Areata

Current research on mesenchymal stem cell therapy for alopecia areata reports improved hair regrowth in a number of case studies and small clinical series, including approaches using umbilical cord-derived and adipose-derived stem cells (see Scientific References). Reported mechanisms include reversing pathological processes contributing to hair loss, supporting regeneration of existing follicles, and in tissue-engineering research, supporting the development of new follicular structures.

How improvement is monitored, not just reported

What the research does not yet show

Most current evidence comes from case reports and small clinical studies rather than large randomized controlled trials, and outcomes vary meaningfully depending on disease pattern (patchy vs. totalis/universalis) and duration. Relapse remains possible even after successful regrowth, regardless of treatment type — this is a feature of alopecia areata’s autoimmune nature, not a treatment failure specifically.

Quick FAQ

Does stem cell therapy prevent alopecia areata from coming back?

Not guaranteed. Relapse can occur with any treatment approach; ongoing monitoring is generally recommended even after visible regrowth.

How soon are improvements typically checked?

Scalp assessment is generally reviewed at 2, 4, and 6 months post-treatment, since follicle regrowth takes time.

Does this work for all types of alopecia areata?

Evidence varies by pattern and extent — patchy alopecia areata has more supporting case data than alopecia totalis or universalis; your specialist will discuss what’s realistic for your specific presentation.

Mechanism of Action in Alopecia Areata

Mesenchymal stem cells derived from umbilical cord tissue are being studied for their capacity to differentiate into relevant cell types and support neovascularization (new blood vessel formation) and immunomodulation when introduced into affected scalp areas — properties researchers believe may help address both the follicle damage and the underlying autoimmune activity in alopecia areata. Stem cells naturally reside within hair follicles themselves, helping maintain a constant supply of new cells throughout life; regenerative approaches aim to support and amplify this natural process where it has stalled.

At Viezec, mesenchymal stem cells are typically sourced from either umbilical cord tissue or adipose (fat) tissue. Beyond hair-specific applications, MSCs are studied broadly in regenerative medicine partly because they offer relatively accessible, low-discomfort collection methods, can be cryogenically stored, and are being researched across three general directions: preventing further tissue damage, repairing existing damage, and informing the development of new regenerative treatments.

For the broader science behind this mechanism, see our Physiological Mechanism of Stem Cell Therapy page. For exosome-specific hair-loss research, see Exosome Treatment for Hair Loss.

Our Promise

Viezec is committed to transparent, evidence-based regenerative medicine care for alopecia areata — not overstated promises. In practice, this means:

• No cure claims. Stem cell therapy is offered as a researched, investigational option to potentially support follicle regeneration and immune regulation — never marketed as a guaranteed cure, and relapse remains possible with any treatment approach.
• Diagnosis before treatment. No stem cell protocol is proposed without a confirmed dermatological diagnosis and evaluation of your specific hair loss pattern and extent.
• Named, credentialed medical oversight. Every treatment plan is reviewed by a qualified regenerative medicine specialist.
• Regulatory transparency. Our protocols operate within India’s regulatory framework for investigational stem cell use, disclosed to patients directly when asked.
• Accredited facilities. Our treatment and cell-processing facilities hold NABH accreditation and NABL accreditation.
• Written, itemized cost estimates. No flat public pricing — cost varies by extent of hair loss and protocol — but a clear written estimate is provided after evaluation.
• Location and access clarity. Our facility is based at H-23/B, Top Floor, Abul Fazal Enclave Part 1, New Delhi – 110025, India, with dedicated international patient support.
• Honest evidence communication. Where clinical evidence is still developing — as it is for alopecia areata specifically — we say so directly and cite the studies our approach draws on.

For our broader quality framework, see Quality Commitment and Why Stem Cell Therapy in India.

Treatment Results of Alopecia Areata at Viezec

Following stem cell treatment, patients are generally monitored for changes across several measures:

1. Visible regrowth and patch coverage — the primary outcome tracked via scalp photography/trichoscopy.
2. Hair quality — texture, thickness, and overall appearance of regrown hair.
3. Shine and scalp condition — secondary indicators often reported alongside regrowth.
4. Hairline definition — particularly relevant for band-pattern (ophiasis) presentations.
5. Disease activity — assessed via hair-pull test and clinical review to gauge relapse risk.

Results vary meaningfully based on disease pattern, duration, extent of hair loss, and individual immune response. For real patient outcomes, see our YouTube channel.

Treatment Disclaimer

Is stem cell therapy a guaranteed cure for alopecia areata?

No. Stem cell therapy for alopecia areata is investigational and may not work for every patient. Depending on evaluation findings, treatment may be declined or the proposed protocol may change based on individual health status. Relapse is possible even after successful regrowth, with any treatment approach.

What does the current evidence show?

Research into stem cell-based approaches for alopecia areata is ongoing, drawing primarily on case reports and small clinical studies (see Scientific References). Results vary by individual, disease pattern, and extent of hair loss; no guarantees or claims of cure are made.

What cell sources are used?

Viezec does not use embryonic or fetal cells in any treatment offered.

Who is this treatment intended for?

Only patients with a confirmed dermatological diagnosis of alopecia areata, following full evaluation. It is not offered as a first-line treatment ahead of standard dermatological care.

Where can I get a specific answer for my case?

Because alopecia areata varies significantly in pattern, extent, and cause, general information on this page cannot replace an individual medical evaluation. Book a consultation with our specialist team in New Delhi.